Search
for
Sort by
Research 151–180 of 1000+
- Analysis of Adverse Drug Reactions in Pediatric Patients with Epilepsy: An Intensive Pharmacovigilance Study
- Autonomous In Situ Biointerfacing Platform for Real-Time Electrophysiological Monitoring and Advanced Wound Management
- Valproate-induced thrombocytopenia
- Post-COVID-19 Syndrome Mechanisms, Prevention and Management
- Establishment of Tsc2-deficient rat embryonic stem cells
- Eclipta prostrata (L.) L.: Traditional Use, Phytochemistry, and Pharmacology
- Blue-gray discoloration of the skin after levofloxacin exposure in a 44-year-old man with pulmonary tuberculosis
- Overlapping of DRESS and Stevens-Johnson syndrome due to first-line antituberculosis drugs: a case report
- Low Serum Biotinidase Activity in Children with Valproic Acid Monotherapy
- Hypertensive urgency in a child with focal epilepsy: Is it sodium valproate induced?
- Clinical Applications of Extracellular Vesicles: Promises and Pitfalls
- Transcranial photobiomodulation for brain diseases: review of animal and human studies including mechanisms and emerging trends
- Mitochondrial DNA 10158T>C mutation in a patient with mitochondrial encephalomyopathy with lactic acidosis, and stroke-like episodes syndrome
- Inhibitory influence of agmatine on catamenial-like seizure susceptibility in progesterone withdrawn female rats
- Alopecia Due to Psychotropic Medications
- Ferulic acid inhibits catamenial epilepsy through modulation of female hormones
- Antiseizure Medication-Induced Alopecia: A Literature Review
- Hydroxytyrosol Alleviates Acute Liver Injury by Inhibiting the TNF-α/PI3K/AKT Signaling Pathway via Targeting TNF-α Signaling
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Encapsulation of Curcumin in Polystyrene-Based Nanoparticles—Drug Loading Capacity and Cytotoxicity
- Valproic acid in childhood epilepsy: anticonvulsive efficacy in relation to its plasma levels.
- Adenosine and Its Receptors in the Pathogenesis and Treatment of Inflammatory Skin Diseases
- Drug-associated insomnia: A pharmacovigilance study based on FDA adverse event reporting system
- Phytochemicals and Nano-Phytopharmaceuticals Use in Skin, Urogenital and Locomotor Disorders: Are We There?
- WNT Signaling in Disease
- Prolactin: A Mammalian Stress Hormone and Its Role in Cutaneous Pathophysiology
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- Asymptomatic SARS-COV2 Infection or COVID-19 vaccination effect for severe multisystem inflammatory syndrome in a 6-year-old girl: case report and review of the literature
- Hair
- Current state of knowledge on the use of cannabidiol (CBD) in various medical conditions